ACE-I und ARB bei chronischen Nierenerkrankungen: Was muss ich berücksichtigen?

Volume: 143, Issue: 12, Pages: 880 - 885
Published: Jun 1, 2018
Abstract
Proteinuric kidney disease, especially in the early and middle stages of renal insufficiency, may be favorably affected by ACE-I/ARB. The progression of renal insufficiency is thereby slowed down and dialysis obligation occurs later or can even be avoided. This effect is independent of the underlying glomerular kidney disease. In the advanced stage of renal insufficiency, the benefit of ACE-I/ARB cannot yet be conclusively assessed. The...
Paper Details
Title
ACE-I und ARB bei chronischen Nierenerkrankungen: Was muss ich berücksichtigen?
Published Date
Jun 1, 2018
Journal
Volume
143
Issue
12
Pages
880 - 885
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.